Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Genome Research
|
October 28, 2005
Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27
Natalay Kouprina, Adam Pavlicek, Vladimir N Noskov, et al.
Plos One
|
June 30, 2012
A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation
Nathan V Lee, Maruja E Lira, Adam Pavlicek, et al.
Plos Biology
|
March 27, 2004
Accelerated evolution of the ASPM gene controlling brain size begins prior to human brain expansion
Natalay Kouprina, Adam Pavlicek, Ganeshwaran H Mochida, et al.
Human Mutation
|
January 12, 2008
Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD)
Steven Bentivegna, Jianbiao Zheng, Eugeni Namsaraev, et al.
Genes, Chromosomes & Cancer
|
June 27, 2012
Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families
Natalay Kouprina, Nicholas C O Lee, Adam Pavlicek, et al.
Journal of the National Cancer Institute
|
September 24, 2014
Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data
Antonio F Di Narzo, Sabine Tejpar, Simona Rossi, et al.
Nucleic Acid Therapeutics
|
February 6, 2025
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations
Patrik Andersson, Sebastien A Burel, Heather Estrella, et al.
Molecular Cancer Therapeutics
|
February 8, 2017
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
Xinqiang Huang, Jill Magnus, Vivek Kaimal, et al.
Molecular Cancer Therapeutics
|
March 16, 2021
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor Therapy
David M Briere, Shuai Li, Andrew Calinisan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2012
Biomarker and pharmacologic evaluation of the γ-secretase inhibitor PF-03084014 in breast cancer models
Cathy C Zhang, Adam Pavlicek, Qin Zhang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Genome Research
|
October 28, 2005
Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27
Natalay Kouprina, Adam Pavlicek, Vladimir N Noskov, et al.
Plos One
|
June 30, 2012
A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation
Nathan V Lee, Maruja E Lira, Adam Pavlicek, et al.
Plos Biology
|
March 27, 2004
Accelerated evolution of the ASPM gene controlling brain size begins prior to human brain expansion
Natalay Kouprina, Adam Pavlicek, Ganeshwaran H Mochida, et al.
Human Mutation
|
January 12, 2008
Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD)
Steven Bentivegna, Jianbiao Zheng, Eugeni Namsaraev, et al.
Genes, Chromosomes & Cancer
|
June 27, 2012
Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families
Natalay Kouprina, Nicholas C O Lee, Adam Pavlicek, et al.
Journal of the National Cancer Institute
|
September 24, 2014
Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data
Antonio F Di Narzo, Sabine Tejpar, Simona Rossi, et al.
Nucleic Acid Therapeutics
|
February 6, 2025
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations
Patrik Andersson, Sebastien A Burel, Heather Estrella, et al.
Molecular Cancer Therapeutics
|
February 8, 2017
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
Xinqiang Huang, Jill Magnus, Vivek Kaimal, et al.
Molecular Cancer Therapeutics
|
March 16, 2021
The KRAS<sup>G12C</sup> Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor Therapy
David M Briere, Shuai Li, Andrew Calinisan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2012
Biomarker and pharmacologic evaluation of the γ-secretase inhibitor PF-03084014 in breast cancer models
Cathy C Zhang, Adam Pavlicek, Qin Zhang, et al.
Page
of 3